Welcome to LookChem.com Sign In|Join Free
  • or
Benzenemethanol, 3-[2-(2,6-dimethyl-1-piperidinyl)ethyl]-α-phenyl-, also known as α-phenyl-3-[2-(2,6-dimethyl-1-piperidinyl)ethyl]benzenemethanol, is a complex organic compound with the molecular formula C21H27NO. It is a derivative of benzenemethanol, featuring a phenyl group attached to the α-carbon, and a 2,6-dimethyl-1-piperidinylethyl group connected to the 3-position of the benzene ring. Benzenemethanol, 3-[2-(2,6-dimethyl-1-piperidinyl)ethyl]-a-phenyl- is known for its potential applications in the pharmaceutical industry, particularly as a precursor in the synthesis of certain drugs. Its structure provides a unique combination of aromatic and aliphatic characteristics, which can contribute to its reactivity and biological activity.

60695-25-2

Post Buying Request

60695-25-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60695-25-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 60695-25-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,9 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 60695-25:
(7*6)+(6*0)+(5*6)+(4*9)+(3*5)+(2*2)+(1*5)=132
132 % 10 = 2
So 60695-25-2 is a valid CAS Registry Number.

60695-25-2Downstream Products

60695-25-2Relevant academic research and scientific papers

Bulky amine analogues of ketoprofen: Potent antiinflammatory agents

Schlegel,Zenitz,Fellows,Laskowski,Behn,Phillips,Botton,Speight

, p. 1682 - 1690 (2007/10/02)

Replacement of the carboxyl group of 2-(3-benzoylphenyl)propionic acid (Ketoprofen) with various bulky amines has produced a series of highly active antiinflammatory agents that have reduced intestinal ulcerogenicity and have better therapeutic ratios in the 21-day adjuvant arthritis assay on rats than currently marketed nonsteroidal antiinflammatory drugs. Activity is maintained on reduction of these 2-(3-benzoylphenyl)propyl bulky amines to the corresponding alcohols or methylene analogues, on conversion of the ketone function to a primary amine or oxime, and on introduction of a 4-halo substituent (Cl or F) on the terminal aromatic ring. Removal of the α-CH3 group greatly reduces the antiinflammatory activity of the series. These compounds have been synthesized by the reductive amination of 2-(3-bromophenyl)propionaldehyde with the respective amine followed by lithiation of this product and condensation with the appropriate benzonitrile.

4-[[3-[α-Aminobenzyl]phenyl]methyl]morpholine and 4-[-[3-benzoylphenyl]ethyl]morpholine

-

, (2008/06/13)

N-{2, 3- and 4-[R1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines, useful as anti-inflammatory agents, are prepared either by reduction of 2-, 3- or 4-[R1 -(phenyl)-CO]-phenyl-lower-alkanoylamines, which are also useful as anti-inflammatory agents; by benzoylating a phenyl-lower-alkylamine; by reaction of a 2-, 3- or 4-lithiophenyl-lower-alkylamine with a R1 -(phenyl)-carboxaldehyde, a R1 -(phenyl)-lower-alkyl ketone or a R1 -(phenyl)-carbonitrile; by reaction of a 2-, 3- or 4-[R1 -(phenyl)-CO]-phenyl-lower-alkyl tosylate with an appropriate amine; or by transformations involving manipulations of a carbonyl or carbinol group.

Intermediates for preparing anti-inflammatory phenyl-lower-alkylamines

-

, (2008/06/13)

N-{3- and 4-[R1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines, useful as anti-inflammatory agents, are prepared either by reduction of 3- or 4-[R1 -(phenyl)-CO]-phenyl-lower-alkanoylamines, which are also useful as anti-inflammatory agents; by benzoylating a phenyl-lower-alkylamine; by reaction of a 3- or 4-lithiophenyl-lower-alkylamine with a R1 -(phenyl)-carboxaldehyde, a R1 -(phenyl)-lower-alkyl ketone or a R1 -(phenyl)-carbonitrile or by transformations involving manipulations of a carbonyl or carbinol group.

Anti-inflammatory phenyl-lower-alkylamines

-

, (2008/06/13)

N-{3-[R1 -(phenyl)-C(=X)]-phenyl-lower-alkyl}amines having anti-inflammatory utility are prepared either by reduction of a 3-[R1 -(phenyl)-CO]-phenyl-lower-alkanoylamine; by benzoylating a phenyl-lower-alkylamine; by reaction of a 3-lithiophenyl-lower-alkylamine with a R1 -(phenyl)-carboxaldehyde, a R1 -(phenyl)lower-alkyl ketone or a R1 -(phenyl)-carbonitrile or by transformations involving manipulations of a carbonyl or carbinol group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60695-25-2